| Title | Journal of Ocular Pharmacology and Therapeutics |
| Abbreviation | J. Ocul. Pharmacol. Ther. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Ophthalmology (Q2); Pharmacology (Q3); Pharmacology (medical) (Q3) |
| h-index | 68 |
| Overall Rank/Ranking | 10861 |
| SCImago Journal Rank (SJR) | 0.472 |
| Impact Score | 2.11 |
| Publisher | Mary Ann Liebert Inc. |
| Country | United States |
| ISSN | 15577732, 10807683 |
| Best Quartile | Q2 |
| Coverage History | 1987, 1991-1993, 1995-2022 |
Journal of Ocular Pharmacology and Therapeutics is the only multidisciplinary peer-reviewed journal that covers basic and clinical research about biopharmaceuticals that have the potential to prevent, treat, and/or diagnose, ocular diseases and disorders.
The Journal publishes manuscripts, reviews, and letters to the editor related to the pharmacokinetics and pharmacodynamics of biopharmaceuticals related to the treatment of the eye.
The Official Journal of the Association for Ocular Pharmacology and Therapeutics.
Journal of Ocular Pharmacology and Therapeutics is a journal covering the technologies/fields/categories related to Ophthalmology (Q2); Pharmacology (Q3); Pharmacology (medical) (Q3). It is published by Mary Ann Liebert Inc.. The overall rank of Journal of Ocular Pharmacology and Therapeutics is 10861. According to SCImago Journal Rank (SJR), this journal is ranked 0.472. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 68. The best quartile for this journal is Q2.
The ISSN of Journal of Ocular Pharmacology and Therapeutics journal is 15577732, 10807683. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Journal of Ocular Pharmacology and Therapeutics is cited by a total of 559 articles during the last 3 years (Preceding 2022).
The Impact IF 2022 of Journal of Ocular Pharmacology and Therapeutics is 2.11, which is computed in 2023 as per its definition. Journal of Ocular Pharmacology and Therapeutics IF is decreased by a factor of 0.06 and approximate percentage change is -2.76% when compared to preceding year 2021, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2022 of Journal of Ocular Pharmacology and Therapeutics is 2.11. If the same downward trend persists, Impact IF may fall in 2023 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 2.11 |
| 2021 | 2.17 |
| 2020 | 2.13 |
| 2019 | 1.86 |
| 2018 | 1.80 |
| 2017 | 1.88 |
| 2016 | 1.73 |
| 2015 | 1.90 |
| 2014 | 1.85 |
Journal of Ocular Pharmacology and Therapeutics has an h-index of 68. It means 68 articles of this journal have more than 68 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Journal of Ocular Pharmacology and Therapeutics is 15577732, 10807683. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Journal of Ocular Pharmacology and Therapeutics is 10861. According to SCImago Journal Rank (SJR), this journal is ranked 0.472. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 0.472 |
| 2021 | 0.580 |
| 2020 | 0.727 |
| 2019 | 0.650 |
| 2018 | 0.658 |
| 2017 | 0.800 |
| 2016 | 0.685 |
| 2015 | 0.751 |
| 2014 | 0.791 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 10861 |
| 2021 | 8572 |
| 2020 | 6810 |
| 2019 | 7568 |
| 2018 | 7336 |
| 2017 | 5826 |
| 2016 | 6911 |
| 2015 | 6315 |
| 2014 | 5801 |
Journal of Ocular Pharmacology and Therapeutics is published by Mary Ann Liebert Inc.. It's publishing house is located in United States. Coverage history of this journal is as following: 1987, 1991-1993, 1995-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Journal of Ocular Pharmacology and Therapeutics is J. Ocul. Pharmacol. Ther.. This abbreviation ('J. Ocul. Pharmacol. Ther.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Ophthalmology (Q2); Pharmacology (Q3); Pharmacology (medical) (Q3), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Journal of Ocular Pharmacology and Therapeutics latest impact IF is 2.11. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 2.17 (2021) and 1.73 (2016), respectively, in the last 9 years. Moreover, its average IS is 1.94 in the previous 9 years.
The Journal of Ocular Pharmacology and Therapeutics has an SJR (SCImago Journal Rank) of 0.472, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 0.800 in 2017 and the lowest being 0.472 in 2022. Furthermore, the average SJR of the Journal of Ocular Pharmacology and Therapeutics over the previous 9-year period stands at 1.94.
The latest h-index of the Journal of Ocular Pharmacology and Therapeutics is 68.
The Journal of Ocular Pharmacology and Therapeutics is published by the Mary Ann Liebert Inc., with its country of publication being the United States.
The Journal of Ocular Pharmacology and Therapeutics is currently ranked 10861 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 5801 in 2014 and its lowest position of 10861 in 2022.
The standard ISO4 abbreviation for the Journal of Ocular Pharmacology and Therapeutics is J. Ocul. Pharmacol. Ther..
Journal of Ocular Pharmacology and Therapeutics is classified as a journal that the Mary Ann Liebert Inc. publishes.
The Journal of Ocular Pharmacology and Therapeutics encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Journal of Ocular Pharmacology and Therapeutics is assigned the following International Standard Serial Numbers (ISSN): 15577732, 10807683.
The best quartile for the Journal of Ocular Pharmacology and Therapeutics is Q2 (2022).
The Journal of Ocular Pharmacology and Therapeutics coverage history can be summarized as follows: 1987, 1991-1993, 1995-2022.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Qualitative Research | journal | 2108 | SAGE Publications Ltd | 86 | 3.97 |
| Business Strategy Review | journal | 31512 | Wiley-Blackwell Publishing Ltd | 33 | 0.04 |
| Materials Research | journal | 14791 | Universidade Federal de Sao Carlos | 65 | 1.62 |
| International Journal of Applied Linguistics | journal | 7321 | Wiley-Blackwell Publishing Ltd | 51 | 2.00 |
| Journal, Indian Academy of Clinical Medicine | journal | 24608 | Indian Academy of Clinical Medicine | 16 | 0.06 |
| Exploration Geophysics | journal | 16383 | Taylor and Francis Ltd. | 48 | 1.17 |
| Built Environment | journal | 12797 | Alexandrine Press | 43 | 1.15 |
| International Journal of Press/Politics | journal | 954 | SAGE Publications Inc. | 77 | 6.45 |
| Journal of Medical Toxicology | journal | 8639 | Springer New York | 55 | 2.01 |
| Contemporanea | journal | 25908 | Societa Editrice Il Mulino | 5 | 0.11 |
| Year | Impact Score (IS) |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 2.11 |
| 2021 | 2.17 |
| 2020 | 2.13 |
| 2019 | 1.86 |
| 2018 | 1.80 |
| 2017 | 1.88 |
| 2016 | 1.73 |
| 2015 | 1.90 |
| 2014 | 1.85 |
